Press-release for stocks publishing date 2021 - 12

Prices are updated after-hours

publishing date : 2021 - 12 - 14 crawled time : 12:30

save search

Evelo Biosciences Added to Nasdaq Biotechnology Index
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
EVLO | $0.3165 -87.39% 710K

Health Technology

| -96.11% | O: -1.97% H: 2.88% C: -7.52%
technology bioscience index biotech iot nasdaq

Tonix Pharmaceuticals Announces IND Clearance for Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -3.45% | O: -3.62% H: 0.0% C: -0.56%
TNXP | $0.1587 1.21% 1.2% 950K

Health Technology

| -58.39% | O: 5.33% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -3.17% | O: -0.51% H: 0.0% C: 0.0%
tnx-2100 als clearance skin cel sars-cov-2 test t-cell

SL Green Announces Sale of 707 Eleventh Avenue
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
SLG | $52.16 -0.48% 0.0% 1M

Finance

| -29.89% | O: -5.47% H: 2.12% C: 0.52%
sales

KemPharm, Inc. Announces Top-Line Results from Clinical Trial Evaluating the Safety and Pharmacokinetics of “Higher-Dose SDX”
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
KMPH | $5.46 6.04% 0

Manufacturing

| -31.23% | O: -9.75% H: 3.23% C: -0.91%
trial results topline

TG Therapeutics Announces Data from the UNITY-CLL Phase 3 Trial Presented at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
TGTX | $13.99 -1.83% -1.86% 2.7M

Health Technology

| -15.93% | O: -5.49% H: 2.43% C: -2.68%
ema trial therapeutics phase 3

Vivos Therapeutics’ mmRNA Oral Appliance Now Eligible for Medicare Reimbursement
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
VVOS | $2.58 -2.64% -2.71% 75K

Health Technology

| -5.02% | O: -1.43% H: 7.27% C: -8.36%
therapeutics

Antios Therapeutics and Arbutus Biopharma Announce First Patient Dosed in Phase 2a Combination Trial of ATI-2173, AB-729 and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B Virus Infection
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
ABUS | $2.74 -0.36% -0.36% 340K

Health Technology

| -36.93% | O: -2.52% H: 7.76% C: -2.59%
ati-2173 phase 2 hepatitis biopharma ab-729 trial therapeutics infection infections phase 2b chronic hepatitis b

Vera Therapeutics Announces Appointment of Kimball Hall to Board of Directors
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
VERA | $39.94 1.06% 1.05% 770K

Professional, Scientific, and T...

| 55.59% | O: -6.73% H: 1.1% C: -3.8%
therapeutics

OpGen subsidiary Ares Genetics announces the strategic expansion of ARESdb proprietary contents
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
OPGN | $0.581 -5.22% -5.51% 170K

Commercial Services

| -52.71% | O: 0.78% H: 2.31% C: -3.08%
genetic expansion

Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401
Published: 2021-12-14 (Crawled : 12:30) - immatics.com
IMTX | $10.15 -2.59% -2.66% 220K

Health Technology

| -5.87% | O: 2.26% H: 6.01% C: 3.98%
ima401 license

LHV Group results in November 2021
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
FRBA | News | $11.92 -3.25% -3.36% 62K

Finance

| -12.99% | O: 1.98% H: 2.63% C: 0.21%
results group

Luckin Coffee Announces Grand Court of Cayman Islands’ Sanction of Scheme of Arrangement in Cayman Islands
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
LKNCY | $22.0 -1.27% 1M

Accommodation and Food Services

| 85.19% | O: -0.67% H: 0.42% C: -4.41%

Yamana Gold Releases Its Greenhouse Gas Abatement Targets Consistent With a 1.5ºC Science-Based Temperature Scenario
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
AUY | $5.85 -0.68% -0.51% 0

Non-Energy Minerals

| 50.64% | O: -2.04% H: 1.56% C: -0.26%

Osino Announces Assay Results From Infill and Step-Out Drilling Twin Hills Gold Project, Namibia
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130

Communications

| 8.35% | O: 1.65% H: 0.0% C: -1.39%
results

Pasinex Announces Extension To Nevada Option Agreement
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
CYDVF | $0.5554 -51.9% 9.6K

Non-Energy Minerals

| -58.52% | O: 1.11% H: 0.0% C: -5.86%

Immunic, Inc. Publishes Positive Results from the Single and Multiple Ascending Dose Parts of its Phase 1 Clinical Trial of IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor
Published: 2021-12-14 (Crawled : 12:30) - biospace.com/
IMUX | $1.24 0.0% 130K

Health Technology

| -86.88% | O: -3.49% H: 1.75% C: -6.36%
imu-935 trial positive results phase 1 potential positive results

TYME Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections
Published: 2021-12-14 (Crawled : 12:30) - biospace.com/
TYME | $0.3107 -8.21%

Health Technology

| -58.01% | O: 3.15% H: 3.5% C: -4.44%
tyme-19 preclinical infection sars-cov-2 pre-clinical infections

NRx Pharmaceuticals Announces New, Favorable Safety Report for ZYESAMI® (aviptadil) in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19
Published: 2021-12-14 (Crawled : 12:30) - biospace.com/
NRXP | $3.11 1.97% 1.93% 96K

Manufacturing

| -47.77% | O: -3.08% H: 0.0% C: 0.0%
covid-19 zyesami aviptadil als covid

Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program
Published: 2021-12-14 (Crawled : 12:30) - biospace.com/
GBIO | News | $2.995 -8.13% -8.85% 110K

Health Technology